Skip to content

Author

Thakur Gurjeet Singh

We have 7 of 17 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Recent advances in scaffold-based KRASG12C inhibitors: SAR and biological evaluation insights.

Over the past decade, targeting Kirsten rat sarcoma viral oncogene homolog (KRAS) mutations has shifted from being considered an undruggable target to becoming a realistic therapeutic strategy with the development of KRASG12C inhibitors. This mutation replaces glycine with cysteine at codon 12, thereby reducing the GTP...

Tomojit Bhattacharjee, Ankush Kumar, Thakur Gurjeet Singh et al. · 0 citations
Review Sep 2026

Sustainable nanohybrids for environmental remediation: Green synthesis, mechanistic design, AI-driven optimization, and circular economy perspectives.

Environmental pollution, driven by industrialization, urbanization, and intensive agriculture, has unleashed a cascade of hazardous contaminants, heavy metals, synthetic dyes, persistent organic pollutants, and emerging micropollutants, into air, water, and soil. These agents pose profound risks to ecosystems and human...

Aastha Rana, Manish Kumar, Thakur Gurjeet Singh et al. · 0 citations
Open access Sep 2026

Design, Synthesis, Molecular Dynamics, and In Vitro Evaluation of Isatin‐Based Quinazoline Derivatives as Potential Antidiabetic Agents

SJ2 is a promising lead for α‐amylase inhibition, which needs further optimization and biological validation, and future evaluation against α‐glucosidase and relevant in vivo models will be essential to determine the more general antidiabetic potential of this scaffold.

Sahil Jaidka, Ankush Kumar, Christopher Basumatary et al. · 0 citations
Review Aug 2026

Targeting Metabolic Dysfunctions in Cancer through Nanoparticles: Advances in Therapeutic Delivery.

INTRODUCTION Cancer progression is characterized by metabolic reprogramming, including the enhanced Warburg effect, hypoxia-driven adaptations, ferroptosis regulation, and altered lipid metabolism. These metabolic changes promote tumor growth, survival, metastasis, and therapeutic resistance. This review aims to analyz...

Pankaj Popli, Mehak Awasthi, M. Jeengar et al. · 0 citations
Review Sep 2026

Neolignans as emerging anticancer leads: Isolation, chemical diversity, structure-activity relationships.

Neolignans are potential natural product-derived anticancer leads; rational SAR-guided optimization, sophisticated delivery methods, and computational drug development may speed up their clinical translation.

Samarth Kumar, Ankush Kumar, Thakur Gurjeet Singh et al. · 0 citations
Review Aug 2026

Biomimetic cell-membrane-coated metallic nanoparticles in cancer therapy: Design, functional mechanisms, and translational challenges.

Cancer remains a major health concern worldwide, with the need to identify better and more specific treatment measures. The concept of using metallic nanoparticles in drug delivery has attracted significant attention due to their distinct physicochemical characteristics, including surface area, size, and multifunctiona...

Hiti Narula, R. Kamal, Thakur Gurjeet Singh et al. · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.